Compass Therapeutics, Inc. · NASDAQ:CMPX
Lerner Neil bought 2,500 Compass Therapeutics, Inc. shares (Form 4)
Traded Sep 24, 2026 · Filed Sep 25, 2026
On Sep 24, 2026, Lerner Neil (Chief Accounting Officer) bought 2,500 Compass Therapeutics, Inc. shares at US$1.14 for US$2,850, leaving 400,000 shares. Filed Sep 25, 2026 (Form 4).
- Bought
- 2,500 shares
- Price
- US$1.14
- Value
- US$2,850
- Holding after
- 400,000 shares
- Trading plan
- No
- Role
- Chief Accounting Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 24, 2026 | Common Stock | Buy | 2,500 | US$1.14 | 400,000 | Direct |
Source
Related
- Compass Therapeutics, Inc.
- Lerner Neil
- Compass Therapeutics, Inc. shareholders
- Form 4 · Lerner Neil · Oct 2, 2026
- Form 4/A · Lerner Neil · Apr 30, 2026
- Form 4 · Lerner Neil · Apr 29, 2026
- Schedule 13G/A · Vivo Opportunity, LLC · Aug 14, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Schedule 13G/A · Biotechnology Value Fund L P · May 15, 2026
- Form 4/A · Anderman Jonathan · Apr 30, 2026
- Form 4 · Anderman Jonathan · Apr 29, 2026